REFERENCES

Ali T, Roberts DN, Tierney WM.  Long-term safety concerns with proton pump inhibitors. Am J Med. 2009 Oct;122(10):896-903.

Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication–Low Magnesium Levels Can Be Associated With Long- Term Use. http://www.fda.gov/drugs/drugsafety/ucm245011.htm.

Thomson Alan BR, Sauve MD, Kassam N, Kamitakahara H.  Safety of the long-term use of proton pump inhibitors. World J Gastroenterol. 2010 May 21;16 (19): 2323-2330.

Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006 May; 117(5):e817-20.

Pereira SP, Gainsborough N, Dowling RH. Drug- induced hypochlorhydria causes high duodenal bacterial counts in the elderly. Aliment Pharmacol Ther. 1998 Jan;12(1):99-104.

Lombardo L, Foti M, Ruggia O, Chiecchio A. Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol. 2010 Jun;8(6)504-8. Epub 2010 Jan 6.

Ratuapli SK, Ellington TG, O’Neill MT, Umar SB, Harris LA, Foxx- Orenstein AE, et al. Proton Pump Inhibitor Therapy Use Does Not Predispose to Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2012 Feb 14. doi: 10.1038/aig.2012.4 [Epub ahead of print]

Chey WD, Spiegel B. Proton Pump Inhibitors, Irritable Bowel Syndrome, and Small Intestinal Bacterial Overgrowth: Coincidence or Newton’s Third Law Revisited? Clin Gastroenterol Hepatol. 2010;8(6):480-482.

Bauer TM, Steinbruckner B, Brinkmann FE, Ditzen AK, Schwacha H, Aponte JJ, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol. 2001;96(10):2962.
Usai P, Manca R, Cuomo R, Lai MA, Russo L, Boi MF. Effect of gluten- free diet on preventing recurrence of gastroesophageal reflux disease-related symptoms in adult celiac patients with nonerosive reflux disease. J Gastroenterol Hepatol. 2008 Sep;23(9):1368-72.
Austin, GL, Thiny MT, Westman EC, Yancy WS Jr, SHaheen NJ. A very low- carbohydrate diet improves gastroesophageal reflux and its symptoms. Dig Dis Sci. 2006 Aug;51(8);1307-12.
Yancy WS Jr, Provenzale D, Westman EC. Improvement of gastroesophageal reflux disease after initiation of a low-carbohydrate diet: five brief case reports. Altern Ther Health Med 2001 Nov-Dec;7(6):120, 116-9.
Miele E, Staiano A, Tozzi A, Auricchio R, Paparo F, Troncone R. Clinical response to amino acid-based formula in neurologically impaired children with refractory esophagitis. J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):314-9.
Piche T, des Varannes SB, Sacher-Huvelin S, Holst JJ, Cuber JC, Galmiche JP. Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology. 2003 Apr;124(4):894-902
Willard MD et al,  Effects of dietary supplementation of fructo-oligosaccharides on small intestinal bacterial overgrowth in dogs. Am Journal Vet Res. 1994 May;55(5):654-9.
Quigley EMM, et al. Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics. Gastroenterology. 2006 Feb;130(2):S78-S90.
Yu, D et al. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testinf detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011 Mar;60(3):334-40.
Katz, MH. Failing the Acid Test: Benefits of Proton Pump Inhibitors May Not Justify the Risks for Many Users. Arch Int Med. 2010 May;170(9):747-8.
Pallarito K. How Safe Are Popular Reflux Drugs? US News and World Report. 2009 Nov 4. health.usnews.com.
Gray SL, et al. Proton Pump Inhibitor Use, Hip Fracture, and Change in Bone Mineral Density in Postmenopausal Women. Arch Int Med. 2010; 170(9):765-771.
Nason KS, et al. Gastroesophageal reflux disease symptom severity, proton pump inhibitor use, and esophageal carcinogenesis. Arch Surg. 2011 Jul; 146(7):851-8.
Cook MB, et al. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer. 2009 Sep; 101(5):855-859.
Jacobson BC, et al. Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Int Med. 2008 Sep 8; 168(16):1798-1804.
Lacy BE, et al. Pathophysiology, Evaluation, and Treatment of Bloating: Hope, Hype or Hot Air? Gastroenterol Hepatol (NY). 2011 Nov; 7(11):729-739.
Jacobson, BC, et al. Body Mass Index and Symptoms of Gastroesophageal Reflux in Women. N Engl J Med. 2006 Jun 1; 354:2340-2348.
Gerson LB. Current Developments in the Management of Acid- Related GI Disorders. Gastroenterol Hepatol (NY). 2009 Sep; 5(9):613-615.
Wright JV, Lenard L. (2001). Why Stomach Acid Is Good For You. Lanham, Maryland: The Rowman & Littlefield Publishing Group, Inc.
Kim KM, et al. Erosive esophagitis may be related to small intestinal bacterial overgrowth. Scan J Gastroenterol. 2012 Mar 15 [PMID: 22416969]
Fujioka K, Greenway F, Sheard J, Ying Y. The effects of grapefruit on weight and insulin resistance: relationship to the metabolic syndrome. J Med Food. 2006 Spring; 9(1):49-54.
Dow CA, Going SB, CHow HH, Patil BS, Thomson CA. The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults.  Metabolism. 2012 Feb 1 [Epub ahead of print]
Dallas C, Gerbi A, Tenca G, Juchaux F, Bernard FX.  Lipolytic effect of a polyphenolic citrus dry extract of reg orange, grapefruit, orange (SINETROL) in human body fat adipocytes. Mechanism of action by inhibition of cAMP-phosphodiesterase (PDE). Phytomedicine. 2008 Oct; 15(10):783-92.
Gorinstein S, Yamamoto K, Katrich E, Leontowicz H, Lojek A, Leontowicz M, et al. Antioxidative properties of Jaffa sweeties and grapefruit and their influence on lipid metabolism and plasma antioxidative potential in rats. Biosci Biotechnol Biochem. 2003 Apr;67(4):907-10.
Silver HJ, Dietrich MS, Niswender KD.  Effects of grapefruit, grapefruit juice and water preloads on energy balance, weight loss, body composition and cardiometabolic risk in free-living obese adults. Nutrition & Metabolism 2011, 8:8 doi:10.1186/1743-7075-8-8
Bowe WP, Logan AC.  Acne vulgaris, probiotics and the gut-brain-skin axis–back to the future? Gut Pathogens 2011, 3:1.
Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s